Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
26 studies found for:    Open Studies | "Tinea"
Show Display Options
Rank Status Study
1 Not yet recruiting A Randomized Study Evaluating the Safety and Efficacy of Luliconazole Cream in Pediatric Subjects With Tinea Corporis
Condition: Tinea
Interventions: Drug: Luliconazole Cream 1%;   Drug: Vehicle Cream
2 Recruiting Safety and Efficacy of Product 33525 in Pediatric Subjects With Tinea Corporis
Condition: Tinea Corporis
Interventions: Drug: Luliconazole Cream 1%;   Drug: Vehicle Cream
3 Recruiting SB208 for the Treatment of Tinea Pedis
Condition: Tinea Pedis
Interventions: Drug: SB208 2%;   Drug: SB208 4%;   Drug: SB208 16%;   Drug: Vehicle Gel
4 Recruiting Evaluation of Trichoscopy in the Diagnosis of Tinea Capitis
Condition: Tinea Capitis
Intervention: Device: Dermoscopy
5 Not yet recruiting Efficacy and Safety of Product S2G6T-1in Patients With Symptomatic Inflammatory Interdigital Tinea Pedis
Condition: Tinea Pedis
Interventions: Drug: S2G6T-1;   Drug: S2G6T-2;   Drug: S2G6T-3;   Drug: S2G6T-4
6 Not yet recruiting Non-inferiority Phase III Trial Comparing Dapaconazole Cream 2% With Ketoconazole Cream 2% in Patients With Tinea Pedis
Condition: Tinea Pedis
Interventions: Drug: Dapaconazole;   Drug: Ketoconazole
7 Recruiting Study Evaluating the Drug Interaction Potential of Luliconazole Cream 1% in Subjects With Tinea Pedis and Tinea Cruris
Conditions: Tinea Pedis;   Tinea Cruris
Intervention: Drug: Omeprazole 40mg
8 Recruiting Glucosamine Sulphate and Ginkgo Biloba as Antifungal Activity for Treating Tinea Pedis
Condition: Foot Infection Tinea Pedis
Interventions: Drug: infected group;   Drug: control group
9 Not yet recruiting Effectiveness Study of Ketoconazole and Betamethasone to Treat Fungal Infection and Dermatophytosis
Condition: Tinea
Interventions: Drug: Ketoconazole + betamethasone dipropionate;   Drug: Clotrimazole + Dexamethasone acetate
10 Recruiting Nitric Oxide Releasing Solution (NORS) Footbath to Treat Athlete's Foot
Condition: Tinea Pedis
Interventions: Drug: Nitric Oxide;   Drug: Water
11 Recruiting Using a Cold Atmospheric Plasma Device to Treat Skin Disorders
Conditions: Actinic Keratosis;   Acne;   Verruca Plana;   Tinea
Intervention: Device: Non-thermal, atmospheric plasma
12 Recruiting Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of Bergamo
Conditions: Erysipelas;   Impetigo;   Herpes Zoster;   Molluscum Contagiosum;   Warts;   Tinea;   Melanoma;   Actinic Keratosis;   Basal Cell Carcinoma;   Squamous Cell Carcinoma
Interventions: Procedure: Screening;   Device: Tele-dermatology
13 Not yet recruiting Study Efficacy and Safety in Comparative Use of Investigational Product Adjuvant Treatment in Onychomycosis
Condition: Onychomycosis
Interventions: Device: Nailner 2 in 1;   Drug: Ciclopirox 8%
14 Recruiting Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Multi-Site Phase 2b Clinical Study
Condition: Onychomycosis
Interventions: Drug: NVXT topical;   Drug: Placebo (Vehicle) Topical
15 Recruiting Study to Evaluate the Efficacy and Safety of Topical MOB015B in the Treatment of Mild to Moderate Distal Subungual Onychomycosis (DSO)
Condition: Distal Subungual Onychomycosis
Interventions: Drug: MOB015B;   Drug: Ciclopirox 80 mg/g
16 Recruiting A Multi-centre, Double-blind, Randomized, Vehicle-controlled Study of Efficacy and Safety of Topical MOB015B in the Treatment of Mild to Moderate Distal Subungual Onychomycosis (DSO)
Condition: Distal Subungual Onychomycosis
Interventions: Drug: MOB015B;   Drug: MOB015B Vehicle
17 Recruiting Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis
Condition: Onychomycosis
Intervention: Drug: Efinaconazole
18 Recruiting Comparison Between Long-pulsed Nd:YAG, Amorolfine and Combination Treatment in Treating Non-dermatophyte Onychomycosis
Condition: Non-dermatophyte Onychomycosis
Interventions: Device: 1,064nm Long-pulsed Nd:YAG;   Drug: Amorolfine
19 Recruiting Efficacy, Safety, and Tolerability of HTS-519 Insert in Patients With Mild to Moderate Toenail Fungus of the Big Toenail
Condition: Onychomycosis
Intervention: Drug: HTS-519 Insert
20 Recruiting Evaluating the Safety, Tolerability and Preliminary Efficacy of Plasma in Improving the Appearance of Onychomycosis
Condition: Onychomycosis
Interventions: Device: MOE Plasma Delivery System A;   Device: MOE Plasma Delivery System B

   Previous Page Studies Shown (1-20) Next Page (21-26) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.